A substantial body of research indicates that imbalances in the PI3K/AKT pathway are frequently linked to various types of skin cancer, including malignant melanoma, basal cell carcinoma, and cutaneous squamous cell carcinoma, and contribute to poor outcomes (Chamcheu et al., 2019). This evidence concerns the gene AKT1 and melanoma.